Abdominal Aortic Aneurysm

Medtronic Launches New Medical Device In U.S. To Improve Treatment of Aortic Aneurysms

Published in Hospital Business Week, December 14th, 2008

Adding to its recent endovascular aortic repair (EVAR) innovations, Medtronic, Inc. (NYSE: MDT), announced the U.S. launch of the Talent Abdominal Stent Graft on the Xcelerant Hydro Delivery System.

EVAR is a treatment for aortic aneurysm, a dangerous bulge or weakening in the body's main artery that can rupture with fatal consequences if left untreated. In the United States, abdominal aortic aneurysms – the most common type – are responsible for approximately 15,000 deaths annually. Worldwide, it is estimated that more than one million people are living with undiagnosed aortic aneurysms, and that 95 percent of these could be successfully treated if detected before...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Business Week

Source: Hospital Business Week (2008-12-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry